Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 2.61% vs 7.54% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -7.29% vs -3.58% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -3.30% vs 0.95% in Mar 2024
Compare Balance Sheet Results of MPS Pharmaa
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
19.11
10.06
9.05
89.96%
Share Warrants & Outstandings
Total Reserve
-18.03
0.03
-18.06
-60,200.00%
Shareholder's Funds
1.08
10.10
-9.02
-89.31%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.08
-0.05
0.13
260.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.11
0.00
0.11
0.00%
Total Non-Current Liabilities
0.18
-0.05
0.23
460.00%
Current Liabilities
Trade Payables
0.20
0.03
0.17
566.67%
Other Current Liabilities
0.41
0.03
0.38
1,266.67%
Short Term Borrowings
7.46
0.00
7.46
0.00%
Short Term Provisions
0.00
0.06
-0.06
-100.00%
Total Current Liabilities
8.07
0.12
7.95
6,625.00%
Total Liabilities
9.33
10.17
-0.84
-8.26%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
15.17
0.00
15.17
0.00%
Less: Accumulated Depreciation
11.33
0.00
11.33
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
3.83
0.00
3.83
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
2.91
0.00
2.91
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.54
2.23
-1.69
-75.78%
Long Term Loans & Advances
0.00
4.93
-4.93
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
7.28
7.16
0.12
1.68%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.50
0.00
0.50
0.00%
Sundry Debtors
0.01
3.00
-2.99
-99.67%
Cash and Bank
0.00
0.01
-0.01
-100.00%
Other Current Assets
0.00
0.00
0.00
0.00%
Short Term Loans and Advances
1.53
0.00
1.53
0.00%
Total Current Assets
2.05
3.01
-0.96
-31.89%
Net Current Assets (Including Current Investments)
-6.02
2.89
-8.91
-308.30%
Total Current Assets Excluding Current Investments
2.05
3.01
-0.96
-31.89%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.33
10.17
-0.84
-8.26%
Contingent Liabilities
0.04
0.00
0.04
0.00%
Total Debt
7.46
0.00
7.46
0.00%
Book Value per share (adjusted)
0.57
10.03
-9.46
-94.32%
Annual - Borrowings
Borrowings 7.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.61% vs 7.54% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 6.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.29% vs -3.58% in Mar 2024
Annual - Investments
Investments 0.54 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 2.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.30% vs 0.95% in Mar 2024






